Infants
A new study by the London School of Hygiene and Tropical Medicine (LSHTM) and the National University of Singapore (NUS) has found that pneumococcal conjugate vaccines (PCVs) could save almost 700,000 children's lives between their introduction in 2000 and 2030. This would be equivalent to the average
Immunotherapy
The Albanese Labor Government has initiated a groundbreaking new program to support babies with peanut allergies through funding the National Allergy Centre of Excellence (NACE) to deliver the ADAPT Oral Immunotherapy Program. This novel approach aims to change the treatment paradigm for peanut allergy, shifting from strict avoidance to safely
Infants
A nationwide program in Australia will provide daily doses of peanut powder to infants with potentially deadly peanut allergies, aiming to build up their tolerance and potentially lead to remission. The program, offered in 10 pediatric hospitals, is the first national peanut allergy treatment program outside of a clinical trial
Children's hospitals
Australia has launched a nationwide programme to provide life-saving treatment for children with potentially deadly peanut allergies. The initiative, offered in 10 paediatric hospitals, involves daily doses of peanut powder for two years to build up tolerance, under the supervision of doctors. This programme is a world first in a
Disease eradication
The Expanded Programme on Immunization (EPI) has achieved remarkable milestones in the past 50 years, saving an estimated 154 million lives globally, with infants making up a significant majority of the total at 101 million. The EPI was credited with the complete eradication of smallpox in 1980, a monumental achievement
